Of course it is. The what neuralink is touting is the exact same situation that company was in. What happened there was they were creating an application for types of rare retinal blindness with the hopes that some other research would magically come along that makes it apply to other types of blindness and give them a market they could properly scale in. Surprise Surprise, no such deus ex machina occurred and the company could not see a path to profitability.

Neuralink is the exact same, cervical vertebra paralysis has less invasive adaptive mechanisms that are cheaper to implement, so there’s no way this will ever be a profitable approach with that alone. They’re hoping that this will magic into some brain machine interface without any actual hope that is going to happen.

The basic research just isn’t there to be doing this shit, but the investor dollars need to be put somewhere.